
A clinical trial assesses Jiandu granule, a Chinese herbal formula, for preventing oral mucositis in nasopharyngeal carcinoma patients undergoing chemoradiotherapy. The trial included 138 patients, with 69 in the experimental group receiving Jiandu granules alongside standard care. Results show a significant reduction in severe oral mucositis incidence (20.3% vs. 44.9%) with Jiandu granule use, along with a 5.9% incidence of mild/moderate gastrointestinal reactions. This herbal medicine offers promise in improving oral mucositis outcomes during treatment.
Like
Save
Share